Insider Trading Activity Capstone Therapeutics Corp. (OTCMKTS:CAPS) – Insider Sold 4,341,586 shares of Stock

Insider Trading Activity For Capstone Therapeutics Corp. (OTCMKTS:CAPS)

Story continues below

Value Fund L P Biotechnology , Insider of Capstone Therapeutics Corp. (OTCMKTS:CAPS) reportedly Sold 4,341,586 shares of the company’s stock at an average price of 0.06 for a total transaction amount of $260,495.16 SEC Form

Insider Trading History For Capstone Therapeutics Corp. (OTCMKTS:CAPS)

  • On 8/28/2012 Lloyd I Miller III, Major Shareholder, bought 938,064 with an average share price of $0.16 per share and the total transaction amounting to $150,090.24.View SEC Filing
  • On 9/19/2012 Lloyd I Miller III, Major Shareholder, bought 261,183 with an average share price of $0.16 per share and the total transaction amounting to $41,789.28.View SEC Filing
  • On 10/19/2012 John M Holliman III, Chairman, bought 150,000 with an average share price of $0.14 per share and the total transaction amounting to $21,000.00.View SEC Filing
  • On 12/6/2012 Lloyd I Miller III, Major Shareholder, bought 19,750 with an average share price of $0.16 per share and the total transaction amounting to $3,160.00.View SEC Filing
  • On 12/17/2012 Lloyd I Miller III, Major Shareholder, bought 175,000 with an average share price of $0.16 per share and the total transaction amounting to $28,000.00.View SEC Filing
  • On 4/8/2013 Fredric J Feldman, Director, bought 25,000 with an average share price of $0.21 per share and the total transaction amounting to $5,250.00.View SEC Filing
  • On 6/10/2013 Lloyd I Miller III, Major Shareholder, bought 300,000 with an average share price of $0.18 per share and the total transaction amounting to $54,000.00.View SEC Filing
  • Analyst Ratings For Capstone Therapeutics Corp. (OTCMKTS:CAPS)
    These are No ratings tracked in the last 12 months. .
    The current consensus rating for Capstone Therapeutics Corp. (OTCMKTS:CAPS) is N/A (Score: NaN) with a consensus target price of N/A

    Recent Trading Activity for Capstone Therapeutics Corp. (OTCMKTS:CAPS)
    Shares of Capstone Therapeutics Corp. closed the previous trading session at 0.0650 down -0.0050 -7.14% with 400 shares trading hands.

    An ad to help with our costs